Skip to main content
Fig. 4 | Antimicrobial Resistance & Infection Control

Fig. 4

From: In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae

Fig. 4

Therapeutic efficacy of ceftazidime-avibactam against K. pneumoniae strain Y8 infection in mouse. Mice were infected with 2.5 × 106 CFU of strain Y8 via the ip route and then treated with PBS or ceftazidime-avibactam by subcutaneous injection. Their survival was assessed daily for 15 days (n = 10). ∗P < 0.05; ∗∗∗P < 0.001

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us